DENTSPLY SIRONA (NASDAQ:XRAY) Announces Quarterly Earnings Results, Misses Expectations By $0.02 EPS

DENTSPLY SIRONA (NASDAQ:XRAY) issued its earnings results on Thursday. The medical instruments supplier reported $0.29 earnings per share for the quarter, missing analysts’ consensus estimates of $0.31 by ($0.02), FiscalAI reports. The business had revenue of $836.00 million during the quarter, compared to analysts’ expectations of $861.68 million. DENTSPLY SIRONA had a positive return on equity of 20.84% and a negative net margin of 14.99%. DENTSPLY SIRONA updated its FY 2026 guidance to 1.200-1.300 EPS.

Here are the key takeaways from DENTSPLY SIRONA’s conference call:

• DENTSPLY SIRONA lowered its 2026 outlook: sales are now expected to be approximately $3.5 billion, and adjusted EPS $1.20–$1.30, down from prior ranges of $3.5–$3.6 billion and $1.40–$1.50, respectively.
• Q3 revenue fell 7% in constant currency to $836 million, and adjusted EPS declined to $0.29 from $0.42 a year ago. Dental businesses faced lower volumes, planned dealer inventory reductions, and pressure in EMEA.
• Operating cash flow decreased to $32 million from $79 million, primarily due to unfavorable working capital; net debt to EBITDA was 3.4, and management said debt reduction remains a priority.
• Q3 results included a $39 million pre-tax accounting benefit from refining estimates of intercompany profit in inventory transfers; management said it reflects multiple years, is not expected to recur, and is included in the updated EPS outlook.
• Management cited early growth areas, including record Wellspect sales, up 10%, double-digit U.S. growth in MIS implants, and a return to growth in U.S. endodontics. It is expanding sales coverage and clinical education, while cautioning that broader, sustained improvement is still needed.

DENTSPLY SIRONA Stock Performance

XRAY traded down $0.56 during midday trading on Thursday, reaching $10.09. The company had a trading volume of 7,842,097 shares, compared to its average volume of 4,910,097. The business has a 50-day moving average of $9.65 and a two-hundred day moving average of $11.30. The company has a quick ratio of 1.07, a current ratio of 1.63 and a debt-to-equity ratio of 1.48. DENTSPLY SIRONA has a 1 year low of $8.32 and a 1 year high of $14.76. The company has a market cap of $2.01 billion, a P/E ratio of -3.67, a P/E/G ratio of 1.25 and a beta of 0.87.

Analyst Ratings Changes

A number of brokerages have recently issued reports on XRAY. Mizuho dropped their price target on shares of DENTSPLY SIRONA from $14.00 to $12.00 and set a “neutral” rating on the stock in a report on Thursday, October 22nd. Leerink Partners decreased their price objective on shares of DENTSPLY SIRONA from $14.00 to $10.00 and set a “market perform” rating for the company in a report on Wednesday, October 14th. Barrington Research lowered their price objective on shares of DENTSPLY SIRONA from $15.00 to $13.00 and set an “outperform” rating on the stock in a research report on Monday, October 26th. Piper Sandler dropped their target price on shares of DENTSPLY SIRONA from $14.00 to $12.00 and set a “neutral” rating on the stock in a report on Friday, October 9th. Finally, BMO Capital Markets decreased their target price on shares of DENTSPLY SIRONA from $13.00 to $10.00 and set a “market perform” rating for the company in a research note on Thursday, September 17th. Three analysts have rated the stock with a Buy rating, eight have issued a Hold rating and three have given a Sell rating to the company. According to MarketBeat, the company has a consensus rating of “Hold” and an average price target of $12.62.

About DENTSPLY SIRONA

DENTSPLY SIRONA is a global manufacturer of professional dental products and technologies. The company serves dentists, dental specialists, dental laboratories and other oral health professionals with solutions used in preventive, restorative, prosthetic, endodontic and implant dentistry.

Its portfolio includes dental equipment, imaging and treatment systems, CAD/CAM technology, consumable dental materials, orthodontic products, endodontic instruments and solutions, dental implants, prosthetic components and laboratory products.